Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24470105 | 0.95 | USP7 (0.33) | — | |
| Trifluoroacetic Acid SCHEMBL29670394 | 0.87 | OPRM1 (0.32) | F11KLKB1 | |
| Trifluoroacetic Acid SCHEMBL29670253 | 0.87 | HSP90AA1 (0.33) | F11KLKB1 | |
| SCHEMBL24469867 | 0.84 | CRBN (0.36) | — | |
| SCHEMBL24469763 | 0.83 | USP7 (0.33) | — | |
| SCHEMBL24484130 | 0.83 | CCNC (0.32) | — | |
| SCHEMBL24469913 | 0.81 | OPRM1 (0.33) | — | |
| SCHEMBL24469920 | 0.81 | HSP90AA1 (0.35) | — | |
| Trifluoroacetic Acid SCHEMBL29670456 | 0.79 | CHRM4 (0.35) | F11KLKB1 | |
| SCHEMBL24470113 | 0.78 | GPR119 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820773-B2 | Tricyclic compounds | ALIGOS THERAPEUTICS, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20220169650-A1 | TRICYCLIC COMPOUNDS | ALIGOS THERAPEUTICS, INC. | 2022-06-02 | — | — | US | disclosed |
| WO-2022115384-A1 | TRICYCLIC COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169650-A1 | TRICYCLIC COMPOUNDS | SLC10A1, PKD1, CEL | F11 1498/4885KLKB1 2634/4885 |
| US-11820773-B2 | Tricyclic compounds | SLC10A1, PKD1, CEL | F11 1498/4885KLKB1 2634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.